Therapeutic vaccines for malignant brain tumors
Michael P Gustafson1, Keith L Knutson2, Allan B Dietz11Division of Transfusion Medicine; 2Department of Immunology, Mayo Clinic, Rochester, MN, USAAbstract: Malignant gliomas are the most common and aggressive form of brain tumors. Current therapy consists of surgical resection, followed by radiatio...
Guardado en:
Autores principales: | Michael P Gustafson, Keith L Knutson, Allan B Dietz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f65d90bae6a4a418e4c23d5691528e6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Therapeutic antitumor efficacy of tumor-derived autophagosome (DRibble) vaccine on head and neck cancer
por: Su H, et al.
Publicado: (2015) -
Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic
por: An S, et al.
Publicado: (2013) -
Therapeutic vaccines and cancer: focus on DPX-0907
por: Karkada M, et al.
Publicado: (2014) -
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies
por: Capolla S, et al.
Publicado: (2015) -
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
por: Kanwar JR, et al.
Publicado: (2012)